Showing results (391-400 of 682) with videos related to

Sort By:
Pageof 69
Cancer Research|September 1, 1992
Comparative antitumor effects of hormonal ablation, estrogen agonist, estrogen cytotoxic derivative, and antiestrogen in the PAIII rat prostatic adenocarcinomaB L Neubauer, K L Best, R L Goode, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 16, 2017
Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future DirectionsSiddhartha P Kar, Andrew Berchuck, Simon A Gayther, et al.
Molecular Oncology|July 24, 2025
Single-cell transcriptomics redefines focal neuroendocrine differentiation as a distinct prostate cancer pathologyRosalia Quezada Urban, Shivakumar Keerthikumar, Ashlee Clark, et al.
Human Heredity|November 30, 2000
Genetic linkage analysis of prostate cancer families to Xq27-28M A Peters, G P Jarvik, M Janer, et al.
American Journal of Human Genetics|May 23, 2000
A genomic scan of families with prostate cancer identifies multiple regions of interestM Gibbs, J L Stanford, G P Jarvik, et al.
NPJ Digital Medicine|May 14, 2026
A human-in-the-loop explanation framework for morphologically transparent AI predictions from whole-slide imagesPeiliang Lou, Yitan Zhu, Nicholas Chia, et al.
Gynecologic Oncology|August 5, 2022
Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancerAmanika Kumar, Chen Wang, Shannon P Sheedy, et al.
Genome Medicine|November 17, 2016
Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissueTanjina Kader, David L Goode, Stephen Q Wong, et al.
BMC Medical Genomics|February 1, 2014
Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancerDevin C Koestler, Prabhakar Chalise, Mine S Cicek, et al.
Gynecologic Oncology|April 11, 2022
Germline BRCA variants, lifestyle and ovarian cancer survivalKate Gersekowski, Rachel Delahunty, Kathryn Alsop, et al.
Pageof 69